Trevisan S

No ORCID on file · 3 papers in corpus
2018
Endometrial thickness on the day of embryo transfer is a poor predictor of IVF treatment outcome.
Human reproduction open ·doi:10.1093/hropen/hox031

Study questionWhat is the independent contribution of endometrial thickness (EMT) on day of embryo transfer to achieving an ongoing pregnancy and live birth after IVF treatment?Summary answerEMT is a poor predictor of IVF success and has on…

2016
Subcutaneous Progesterone Is Effective and Safe for Luteal Phase Support in IVF: An Individual Patient Data Meta-Analysis of the Phase III Trials.
PloS one ·doi:10.1371/journal.pone.0151388

ObjectiveTo summarize efficacy and safety data on a new progesterone compound which is available for subcutaneous administration as compared to vaginally administered progesterone for luteal phase support in patients undergoing IVF treatmen…

2014
A randomized, controlled trial comparing the efficacy and safety of aqueous subcutaneous progesterone with vaginal progesterone for luteal phase support of in vitro fertilization.
Human reproduction (Oxford, England) ·doi:10.1093/humrep/deu194

Study questionIs the ongoing pregnancy rate with a new aqueous formulation of subcutaneous progesterone (Prolutex(®)) non-inferior to vaginal progesterone (Endometrin(®)) when used for luteal phase support of in vitro fertilization?Summary …